365 related articles for article (PubMed ID: 28204996)
1. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
2. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
[TBL] [Abstract][Full Text] [Related]
3. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
[TBL] [Abstract][Full Text] [Related]
4. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
[TBL] [Abstract][Full Text] [Related]
5. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
[TBL] [Abstract][Full Text] [Related]
6. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
[TBL] [Abstract][Full Text] [Related]
7. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
[No Abstract] [Full Text] [Related]
8. Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.
Potthoff K; Stötzer O; Söling U; Hansen R; Harde J; Dille S; Nusch A; Marschner N
Clin Breast Cancer; 2020 Jun; 20(3):e315-e326. PubMed ID: 32273207
[TBL] [Abstract][Full Text] [Related]
9. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
10. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
[TBL] [Abstract][Full Text] [Related]
11. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
12. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
[TBL] [Abstract][Full Text] [Related]
13. Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.
Fernandes R; Mazzarello S; Hutton B; Shorr R; Majeed H; Ibrahim MF; Jacobs C; Ong M; Clemons M
Support Care Cancer; 2016 Aug; 24(8):3633-50. PubMed ID: 27146496
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
[TBL] [Abstract][Full Text] [Related]
15. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
[TBL] [Abstract][Full Text] [Related]
16. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
Maxwell C
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
[TBL] [Abstract][Full Text] [Related]
18. Current methods for the assessment and management of taxane-related neuropathy.
Smith EM
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
[TBL] [Abstract][Full Text] [Related]
19. Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy.
Rattanakrong N; Siriphorn A; Boonyong S
Sci Rep; 2022 Jun; 12(1):10632. PubMed ID: 35739233
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]